GlaxoSmithKlins (GSK) and Amicus Therapeutics (FOLD) Announces Amigal Collaboration' Amicus to Receive $30M Upfront, $170M in Potential Milestones

Go back to GlaxoSmithKlins (GSK) and Amicus Therapeutics (FOLD) Announces Amigal Collaboration' Amicus to Receive $30M Upfront, $170M in Potential Milestones